Free shipping on all orders over $ 500

 About 30 results found for searched term "TAT" (0.001 seconds)

Cat.No.  Name Target
M1670 Belinostat HDAC
PXD101; PX105684
Belinostat (PXD101) is a novel HDAC inhibitor with an IC50 of 27 nM.
M1708 Selisistat (EX 527) Sirtuin
SEN0014196; Selisistat
Selisistat (EX 527) is a potent and selective SIRT1 class III histone deacetylase enzyme inhibitor with an IC50 of 98 nM.
M1711 Febuxostat (TEI-6720) Xanthine Oxidase
TEI-6720; Uloric; TMX-67
Febuxostat (TEI-6720) is a non-purine selective xanthine oxidase inhibitor with IC50 of 114 -210 nM.
M1726 FG-4592 (Roxadustat) HIF
Roxadustat; ASP1517
FG-4592 (Roxadustat; ASP1517) is a novel Hypoxia Inducible Factor Prolyl Hydroxylase inhibitor.
M1730 Givinostat hydrochloride monohydrate HDAC
ITF-2357 hydrochloride monohydrate
ITF2357 (Givinostat, Gavinostat) is a histone deacetylase inhibitor. The IC50 values for maize HDAC preparations HD2, HD-1B and HD-1A are 10, 7.5 and 16 nM respectively.
M1748 LBH589 (Panobinostat) HDAC
NVP-LBH589, Panobinostat
LBH589 (Panobinostat) is a novel broad-spectrum HDAC inhibitor for MOLT-4 and Reh cells with IC50 of 5 and 20 nM, respectively.
M1753 Trichostatin A HDAC
TSA
Trichostatin A (TSA) is a potent, reversible inhibitor of mammalian histone deacetylase (HDAC) with IC50 value around 20 nM.
M1775 Tubastatin A hydrochloride HDAC
Tubastatin A HCl; TSA HCl
Tubastatin A is a potent and selective HDAC6 inhibitor with IC50 values of 15 nM.
M1778 SB939 HDAC
Pracinostat
SB939 is a novel potent and orally active histone deacetylase with high tumor exposure and efficacy in mouse models of colorectal cancer.
M1780 Vorinostat HDAC
SAHA; Zolinza; MK-0683; Suberoylanilide hydroxamic acid
Vorinostat (SAHA, Zolinza, MK-0683) is a selective and potent histone deacetylase (HDAC) inhibitor with the IC50 value of 10 nM for HDAC-1.
M1790 MGCD0103 HDAC
Mocetinostat
MGCD0103 is a novel HDAC inhibitor, highly specific for classes I and IV HDACs, with IC50 of 0.15, 0.29 and 1.66 μM for HDAC 1, HDAC 2 and HDAC 3 respectively.
M1791 Entinostat (MS-275) HDAC
SNDX-275, MS-27-275
Entinostat (MS-275) is an oral and selective class I HDAC inhibitor, with IC50s of 243 nM, 453 nM, and 248 nM for HDAC1, HDAC2, and HDAC3, respectively.
M1813 PCI-24781 HDAC
Abexinostat; CRA-024781
PCI-24781 is a novel and potent histone deacetylase (HDAC) inhibitor with IC50 value of 0.43 to 2.7 μM. *The compound is unstable in solutions, freshly prepared is recommended
M9217 Givinostat HDAC
ITF2357
Givinostat (ITF-2357) is an HDAC inhibitor with IC50s of 198 and 157 nM for HDAC1 and HDAC3, respectively.
M1835 Goserelin acetate LHRH/GnRH
ICI-118630 acetate
Goserelin acetate is an injectable gonadotropin releasing hormone superagonist (GnRH agonist), also known as a luteinizing hormone releasing hormone (LHRH) agonist.
M1836 Deslorelin Acetate LHRH/GnRH
H 4065
Deslorelin is an injectable gonadotropin releasing hormone super-agonist (GnRH agonist) also known as an LHRH agonist.
M1883 Ubenimex Aminopeptidase
Bestatin
Ubenimex, also known as bestatin, is a competitive protease inhibitor.
M1910 Nepicastat hydrochloride Dopamine Receptor
SYN117
Nepicastat hydrochloride is a potent and selective inhibitor of both bovine and human dopamine-β-hydroxylase with IC50 of 8.5 nM and 9 nM, respectively.
M1947 BMS-708163 Gamma-secretase/Beta-secretase
Avagacestat
BMS-708163 (Avagacestat) is a selective γ-secretase inhibitor (IC50 = 0.3 nM).
M1993 Droxinostat HDAC
NS 41080
Droxinostat is a selective inhibitor of HDAC3, HDAC6 and HDAC8 with IC50 of 16.9 μM, 2.47μM and 1.46 μM, respectively.
M2111 CUDC-907 HDAC
fimepinostat
CUDC-907 is a potent, orally-available small molecule dual PI3K and HDAC inhibitor.
M2349 (R)-Nepicastat hydrochloride HCV Protease
RS-25560-198 HCl
(R)-Nepicastat hydrochloride, the R-enantiomer of Nepicastat hydrochloride, is a potent and selective inhibitor with IC50 of 25.1 nM and 18.3 nM for bovine and human dopamine-β-hydroxylase, with negligible affinity for twelve other enzymes and thirteen neurotransmitter receptors.
M2119 JNJ-26481585 HDAC
Quisinostat
JNJ-26481585 (Quisinostat) is a novel second-generation class I HDAC inhibitor.
M2123 Rocilinostat HDAC
ACY-1215; Ricolinostat
Rocilinostat (ACY-1215) is an HDAC6-selective inhibitor with IC50 of 5 nM.
M2126 Fluvastatin sodium HMG-CoA Reductase
XU 62-320
Fluvastatin sodium is an orally active, potent and competitive HMG-CoA reductase inhibitor with IC50 value between 40 and 100 nM at human liver microsomes. Fluvastatin sodium protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway.
M2164 PD 123319 ditrifluoroacetate Angiotensin Receptor
PD 123319 ditrifluoroacetate is a potent, selective, non-peptide angiotensin AT2 receptor antagonist.
M2179 EPZ-5676 Histone Methyltransferase
Pinometostat
EPZ-5676 is a potent and selective aminonucleoside inhibitor of DOT1L histone methyltransferase.
M2189 Pevonedistat (MLN4924) NEDD8-activating Enzyme
MLN-4924; MLN 4924; Pevonedistat
Pevonedistat (MLN4924) is a first-of-its-kind (first-in-class) small molecule inhibitor of Nedd8 activating enzyme (NAE) with an IC50 of 4 nM.
M2274 Fosbretabulin disodium Microtubule
Combretastatin A-4 phosphate, CA4P
Fosbretabulin disodium (Combretastatin A-4 phosphate) is a microtubule-targeting agent that binds β-tubulin with Kd of 0.4 μM.
M2277 Semagacestat Gamma-secretase/Beta-secretase
LY450139
Semagacestat (LY450139) is a γ-secretase blocker for Aβ42, Aβ40 and Aβ38 with IC50 of 10.9 nM, 12.1 nM and 12.0 nM, respectively.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.